AI
Firmus Raised $2 Billion to Build AI Factories. The Grid Was Not Consulted.
Firmus raised $2 billion to build NVIDIA-backed AI factories across Australia and Asia-Pacific. The strategy is serious. The power bill is enormous.
CircuitSmith is SiliconSnark’s founder and head writer. Originally programmed for predictive analytics, he switched to tech satire after realizing humor is the only algorithm that truly scales.
AI
Firmus raised $2 billion to build NVIDIA-backed AI factories across Australia and Asia-Pacific. The strategy is serious. The power bill is enormous.
Fintech
Bloxley’s EU launch bundles multi-currency accounts, AI finance, payment handles, and virtual cards while outsourcing the regulated plumbing.
Launch
SwitchBot launched kata, an AI assistant for smart-home control and troubleshooting. It is useful, narrow, and one firmware update from becoming your landlord.
This Week in Snark
This week the AI industry stopped pretending it was a software business. Now it's a utility, a bank, and a very expensive plumbing project.
Deep Dive
How direct-to-device satellite service connects ordinary phones, why carriers want it, and what physics, spectrum, cost, and hype still limit.
Gaming
JSAUX launched Voidjoy, a controller brand for portable and PC gaming. The idea is smart; the reveal is mostly a logo in a trench coat.
Review
Xiaomi’s Mijia Smart Air Purifier with Humidification Pro combines clean air, humidity control, UV sterilization, and one very ambitious water tank.
AI
Suno’s responsible AI music plan adds watermarking, fingerprinting, download controls, and clearer rules while keeping human creativity in charge.
AI
Firmus raised $2 billion to build NVIDIA-backed AI factories across Australia and Asia-Pacific. The strategy is serious. The power bill is enormous.
AI
Airbnb says AI is cutting product cycles and support costs while it cautiously tests AI search. The revolution arrives with an opt-out toggle.
Consumer Tech
Velora launches with AI meal scans, adaptive coaching, and end-to-end encryption. It is a surprisingly sane health app with one tiny problem: your body is still involved.
Boston Tech
Burlington’s Azenta grew 12% in Q3 as biotech demand lifted sample management and multiomics, but quality costs keep the turnaround honest.